What Is Sjogren's Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention | Everyday Health
Montreal cognitive assessment in primary sjogren's syndrome | Neurosciences Journal
Sjogren syndrome | Osmosis
Limbic Encephalitis as a Heralding Manifestation of Primary Sjogren's Syndrome
Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome
What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren's syndrome? - ScienceDirect
Frontiers | Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions
Advances in understanding the pathogenesis of primary Sjögren's syndrome | Nature Reviews Rheumatology
Sjögren's Syndrome Symptoms You Might Be Ignoring
Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis | Nature Reviews Rheumatology
Vaccines | Free Full-Text | Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
Sjogren's Syndrome: How Dry Am I? | UConn School of Pharmacy
What's New in Sjögren Disease: Update From ACR 2021
Sjogren's Syndrome | UW Orthopaedics and Sports Medicine, Seattle
Sjögren's Syndrome & Long Term Disability - McDonald and McDonald
B cells in the pathogenesis of primary Sjögren syndrome | Nature Reviews Rheumatology
Sjogren Syndrome- a complex CNS disease
Brain Sciences | Free Full-Text | Cognitive Function in Primary Sjögren's Syndrome: A Systematic Review
Environmental factors in the pathogenesis of primary Sjögren's syndrome - Björk - 2020 - Journal of Internal Medicine - Wiley Online Library
GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature
Biomolecules | Free Full-Text | T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Memory Problems in Sjögren's Tied to Global Cognitive Impairment | Study Finds 'Tight Interplay' Between Cognition and Depression
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study - The Lancet Rheumatology
